Establishment of a FeNO Cutoff Value for Evaluating the Response to Budesonide-formoterol in Patients With Chronic Cough Suggestive of Cough Variant Asthma: a Multicenter Prospective Clinical Study
Latest Information Update: 30 Sep 2024
Price :
$35 *
At a glance
- Drugs Budesonide/formoterol (Primary)
- Indications Cough
- Focus Pharmacokinetics
- Acronyms EFFICIENCY
- Sponsors AstraZeneca
- 30 Sep 2024 New trial record